Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FY22A
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,034
Award facts
- Contract value 100% obligated
- $22,034.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,034.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on June 24, 2025, with an ultimate completion date of July 16, 2025, carries no set-aside designation. The award represents a discrete product fulfillment under DMS Pharmaceutical Group's broader pharmaceutical supply relationship with the federal government, specifically supporting military healthcare facility needs.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026. The parent contract enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare systems worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively across the agency's medical product procurement portfolio, which historically encompasses oncology treatments, vaccines, contraceptive devices, and specialty pharmaceutical items.
Quick answers
Who was awarded contract SPE2DB25FY22A?
SPE2DB25FY22A was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 24, 2025.
How much is contract SPE2DB25FY22A worth?
The government has obligated $22,034 on SPE2DB25FY22A.
Is contract SPE2DB25FY22A an order under another contract?
Yes. SPE2DB25FY22A is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22A competed?
The extent of competition for SPE2DB25FY22A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award